Willis Towers Watson (NASDAQ:WLTW) had its target price raised by research analysts at Raymond James from $175.00 to $180.00 in a research report issued to clients and investors on Tuesday. The firm currently has a “strong-buy” rating on the financial services provider’s stock. Raymond James’ price objective would indicate a potential upside of 13.71% from the stock’s current price.
WLTW has been the subject of several other research reports. BidaskClub cut shares of Willis Towers Watson from a “hold” rating to a “sell” rating in a report on Thursday, September 27th. Citigroup boosted their price objective on shares of Willis Towers Watson from $175.00 to $183.00 and gave the stock a “buy” rating in a research report on Thursday, July 12th. Wells Fargo & Co boosted their price objective on shares of Willis Towers Watson from $155.00 to $160.00 and gave the stock a “market perform” rating in a research report on Monday. Zacks Investment Research downgraded shares of Willis Towers Watson from a “hold” rating to a “sell” rating in a research report on Tuesday, August 28th. Finally, Credit Suisse Group upgraded shares of Willis Towers Watson from a “neutral” rating to an “outperform” rating and set a $166.00 price objective for the company in a research report on Monday, October 8th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $172.85.
NASDAQ WLTW opened at $158.30 on Tuesday. The company has a quick ratio of 2.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.44. Willis Towers Watson has a 52 week low of $134.50 and a 52 week high of $164.99. The company has a market cap of $20.10 billion, a price-to-earnings ratio of 18.60, a PEG ratio of 1.34 and a beta of 0.74.
In related news, insider Adam Garrard sold 1,830 shares of the company’s stock in a transaction on Friday, August 31st. The shares were sold at an average price of $146.77, for a total value of $268,589.10. Following the completion of the sale, the insider now owns 13,739 shares in the company, valued at approximately $2,016,473.03. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.50% of the stock is owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Landaas & Co. WI ADV purchased a new stake in Willis Towers Watson in the 2nd quarter valued at $167,000. Advisor Partners LLC purchased a new stake in Willis Towers Watson in the 2nd quarter valued at $209,000. Exane Derivatives purchased a new stake in Willis Towers Watson in the 2nd quarter valued at $214,000. Dupont Capital Management Corp raised its position in Willis Towers Watson by 74.4% in the 2nd quarter. Dupont Capital Management Corp now owns 1,444 shares of the financial services provider’s stock valued at $219,000 after purchasing an additional 616 shares during the last quarter. Finally, Edgestream Partners L.P. purchased a new stake in Willis Towers Watson in the 3rd quarter valued at $213,000. Hedge funds and other institutional investors own 92.89% of the company’s stock.
Willis Towers Watson Company Profile
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. Its Human Capital and Benefits segment provides actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services.
See Also: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Willis Towers Watson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson and related companies with MarketBeat.com's FREE daily email newsletter.